Synthesis and biological evaluation of heterocyclic privileged medicinal structures containing (benz)imidazole unit

[1]  S. T. Moin,et al.  2-Arylquinazolin-4(3H)-ones: A new class of α-glucosidase inhibitors. , 2015, Bioorganic & medicinal chemistry.

[2]  Xiao-feng Han,et al.  New substituted benzimidazole derivatives: a patent review (2013 – 2014) , 2015, Expert opinion on therapeutic patents.

[3]  T. Kwape,et al.  Antioxidant and antimicrobial studies on fused-ring pyrazolones and isoxazolones. , 2014, Bioorganic & medicinal chemistry.

[4]  A. Bouraiou,et al.  2-Halogeno-N-phenacylimidazolium salts and their reactions with active methylene species, arylamines and thiocyanate ions , 2014 .

[5]  V. Padmavathi,et al.  Synthesis, antioxidant, and cytotoxic activities of bis(oxazolyl/thiazolyl/imidazolyl)amidomethanesulfonyl Acetamides , 2014, Medicinal Chemistry Research.

[6]  C. Mohan,et al.  Benzimidazole: an emerging scaffold for analgesic and anti-inflammatory agents. , 2014, European journal of medicinal chemistry.

[7]  S. Maiti,et al.  Anti-cancer therapeutic potential of quinazoline based small molecules via global upregulation of miRNAs. , 2014, Chemical communications.

[8]  Lokman H. Choudhury,et al.  Imidazole as organocatalyst for multicomponent reactions: diversity oriented synthesis of functionalized hetero- and carbocycles using in situ-generated benzylidenemalononitrile derivatives , 2014 .

[9]  K. Ghosh,et al.  Ion conducting cholesterol appended pyridinium bisamide-based gel for the selective detection of Ag+ and Cl− ions , 2014 .

[10]  T. Roisnel,et al.  Reaction of carbon disulfide with 2-bromoimidazolium salts. Novel bicyclic mesoionic thiazolo[3,2-a]imidazoles , 2013 .

[11]  Cheng‐He Zhou,et al.  Design, synthesis and antimicrobial evaluation of novel benzimidazole type of Fluconazole analogues and their synergistic effects with Chloromycin, Norfloxacin and Fluconazole. , 2013, European journal of medicinal chemistry.

[12]  Abdelouahid Samadi,et al.  Nontoxic and neuroprotective β-naphthotacrines for Alzheimer's disease. , 2013, Chemical research in toxicology.

[13]  R. Cacabelos,et al.  Novel tacrine-related drugs as potential candidates for the treatment of Alzheimer's disease. , 2013, Bioorganic & medicinal chemistry letters.

[14]  T. Roisnel,et al.  Synthesis, crystal structure and antibacterial activity of new highly functionalized ionic compounds based on the imidazole nucleus. , 2013, Bioorganic & medicinal chemistry letters.

[15]  Lu Xu,et al.  Molecular docking and synthesis of novel quinazoline analogues as inhibitors of transcription factors NF-κB activation and their anti-cancer activities. , 2013, Bioorganic & medicinal chemistry.

[16]  S. Saha,et al.  I2-Catalyzed three-component protocol for the synthesis of quinazolines , 2012 .

[17]  C. Pérez,et al.  Synthesis, biological assessment, and molecular modeling of racemic 7-aryl-9,10,11,12-tetrahydro-7H-benzo[7,8]chromeno[2,3-b]quinolin-8-amines as potential drugs for the treatment of Alzheimer's disease. , 2012, European journal of medicinal chemistry.

[18]  Changlin Zhou,et al.  Synthesis and evaluation of anti-tubercular and antibacterial activities of new 4-(2,6-dichlorobenzyloxy)phenyl thiazole, oxazole and imidazole derivatives. Part 2. , 2012, European journal of medicinal chemistry.

[19]  J. Ham,et al.  Synthesis of substituted benzimidazolyl curcumin mimics and their anticancer activity. , 2012, Bioorganic & medicinal chemistry letters.

[20]  Y Wang,et al.  Recent researches in triazole compounds as medicinal drugs. , 2012, Current medicinal chemistry.

[21]  O. Firuzi,et al.  Synthesis, cytotoxicity and calcium antagonist activity of novel imidazolyl derivatives of 1,8-acridinediones , 2011 .

[22]  A. M. Vijesh,et al.  Hantzsch reaction: synthesis and characterization of some new 1,4-dihydropyridine derivatives as potent antimicrobial and antioxidant agents. , 2011, European journal of medicinal chemistry.

[23]  Y. R. Lee,et al.  Ca(OH)2-mediated efficient synthesis of 2-amino-5-hydroxy-4H-chromene derivatives with various substituents , 2011 .

[24]  G. Clarkson,et al.  Origins of stereoselectivity in optically pure phenylethaniminopyridine tris-chelates M(NN')3(n+) (M = Mn, Fe, Co, Ni and Zn). , 2011, Dalton transactions.

[25]  M. Burnier,et al.  Pharmacokinetic evaluation of losartan , 2011, Expert opinion on drug metabolism & toxicology.

[26]  A. Morreale,et al.  Synthesis, biological assessment and molecular modeling of 14-aryl-10,11,12,14-tetrahydro-9H-benzo[5,6]chromeno[2,3-b]quinolin-13-amines. , 2011, Bioorganic & medicinal chemistry letters.

[27]  A. Sivakumar,et al.  Synthesis, Characterization of Some New Five Membered Heterocycles Based on Imidazole Moiety and their Applications on Therapeutics , 2011 .

[28]  P. Markt,et al.  Characterization of new PPARgamma agonists: benzimidazole derivatives-importance of positions 5 and 6, and computational studies on the binding mode. , 2010, Bioorganic & medicinal chemistry.

[29]  Z. Incesu,et al.  Synthesis of 2-substituted-N-[4-(1-methyl-4,5-diphenyl-1H-imidazole-2-yl)phenyl]acetamide derivatives and evaluation of their anticancer activity. , 2010, European journal of medicinal chemistry.

[30]  Ashutosh Kumar,et al.  Synthesis and molecular docking studies of 1-phenyl-4-glycosyl-dihydropyridines as potent antileishmanial agents. , 2010, European journal of medicinal chemistry.

[31]  T. Raj,et al.  Cytotoxic activity of 3-(5-phenyl-3H-[1,2,4]dithiazol-3-yl)chromen-4-ones and 4-oxo-4H-chromene-3-carbothioic acid N-phenylamides. , 2010, European journal of medicinal chemistry.

[32]  M. Radi,et al.  Synthesis, biological evaluation, and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis: part 2. Synthesis of rigid pyrazolones. , 2009, Bioorganic & medicinal chemistry.

[33]  R. Hsung,et al.  Regio- and stereoselective isomerizations of allenamides: synthesis of 2-amido-dienes and their tandem isomerization-electrocyclic ring-closure. , 2009, Organic letters.

[34]  Ashutosh Kumar Singh,et al.  Antimicrobial studies of some novel quinazolinones fused with [1,2,4]-triazole, [1,2,4]-triazine and [1,2,4,5]-tetrazine rings. , 2009, European journal of medicinal chemistry.

[35]  Michael W Parker,et al.  Identification and characterization of a new cognitive enhancer based on inhibition of insulin‐regulated aminopeptidase , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[36]  F. J. Luque,et al.  New tacrine-dihydropyridine hybrids that inhibit acetylcholinesterase, calcium entry, and exhibit neuroprotection properties. , 2008, Bioorganic & medicinal chemistry.

[37]  M. Rueping,et al.  Asymmetric organocatalysis: an efficient enantioselective access to benzopyranes and chromenes. , 2008, Chemistry.

[38]  K. Syrigos,et al.  Safety and efficacy of zoledronic acid rapid infusion in lung cancer patients with bone metastases: a single institution experience. , 2008, Anticancer research.

[39]  P. Yogeeswari,et al.  An atom efficient, solvent-free, green synthesis and antimycobacterial evaluation of 2-amino-6-methyl-4-aryl-8-[(E)-arylmethylidene]-5,6,7,8-tetrahydro-4H-pyrano[3,2-c]pyridine-3-carbonitriles. , 2007, Bioorganic & medicinal chemistry letters.

[40]  M. Gottardis,et al.  Imidazole moiety replacements in the 3-(1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-one inhibitors of insulin-like growth factor receptor-1 (IGF-1R) to improve cytochrome P450 profile. , 2007, Bioorganic & medicinal chemistry letters.

[41]  Toshio Suzuki,et al.  Practical aldol reaction of trimethylsilyl enolate with aldehyde catalyzed by N-methylimidazole as a Lewis base catalyst , 2006 .

[42]  Stuart C. Wilson,et al.  Targeting the alpha-folate receptor with cyclopenta[g]quinazoline-based inhibitors of thymidylate synthase. , 2006, Bioorganic & medicinal chemistry.

[43]  J. Pérez-Ruixo,et al.  Population pharmacokinetics of tipifarnib in healthy subjects and adult cancer patients. , 2006, British journal of clinical pharmacology.

[44]  P. Bernardi,et al.  High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening , 2006, Archives of Toxicology.

[45]  M. Kidwai,et al.  Aqua mediated synthesis of substituted 2-amino-4H-chromenes and in vitro study as antibacterial agents. , 2005, Bioorganic & medicinal chemistry letters.

[46]  E. Débiton,et al.  Cytotoxic effects of 100 reference compounds on Hep G2 and HeLa cells and of 60 compounds on ECC-1 and CHO cells. I mechanistic assays on ROS, glutathione depletion and calcein uptake. , 2005, Toxicology in vitro : an international journal published in association with BIBRA.

[47]  Yanguang Wang,et al.  Unexpected reaction of dimethyl acetylenedicarboxylate with in situ generated arylketenes catalyzed by 1-methylimidazole. , 2005, Organic letters.

[48]  J. M. Dickinson,et al.  2-pyrones possessing antimicrobial and cytotoxic activities. , 2004, Bioorganic & medicinal chemistry.

[49]  F. J. Luque,et al.  Synthesis, biological evaluation and molecular modelling of diversely functionalized heterocyclic derivatives as inhibitors of acetylcholinesterase/butyrylcholinesterase and modulators of Ca2+ channels and nicotinic receptors. , 2004, Bioorganic & medicinal chemistry.

[50]  P. Sokoloff,et al.  Development of Novel 1,2,3,4‐Tetrahydroisoquinoline Derivatives and Closely Related Compounds as Potent and Selective Dopamine D3 Receptor Ligands , 2004, Chembiochem : a European journal of chemical biology.

[51]  L. Doyle,et al.  Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2) , 2003, Oncogene.

[52]  A. Shafiee,et al.  Synthesis and Evaluation of Pharmacological Activities of 3, 5‐Dialkyl 1, 4‐Dihydro‐2, 6‐Dimethyl‐4‐Nitroimidazole‐3, 5‐Pyridine Dicarboxylates , 2003, Archiv der Pharmazie.

[53]  K. He,et al.  Imidazole alkaloids from Lepidium meyenii. , 2003, Journal of natural products.

[54]  C. Marosi,et al.  Second-line chemotherapy with dacarbazine and fotemustine in nitrosourea-pretreated patients with recurrent glioblastoma multiforme , 2003, Anti-cancer drugs.

[55]  D. Cheney,et al.  Inhibitors of inosine monophosphate dehydrogenase: SARs about the N-[3-Methoxy-4-(5-oxazolyl)phenyl moiety. , 2003, Bioorganic & medicinal chemistry letters.

[56]  M. Shamsipur,et al.  Quantitative Structure‐Activity Relationship Study of Recently Synthesized 1, 4‐Dihydropyridine Calcium Channel Antagonists. Application of the Hansch Analysis Method , 2002, Archiv der Pharmazie.

[57]  J Kaustová,et al.  Influence of the replacement of the oxo function with the thioxo group on the antimycobacterial activity of 3-aryl-6,8-dichloro-2H-1,3-benzoxazine-2,4(3H)-diones and 3-arylquinazoline-2,4(1H,3H)-diones. , 2001, Farmaco.

[58]  J. Baños,et al.  Synthesis and acetylcholinesterase/butyrylcholinesterase inhibition activity of new tacrine-like analogues. , 2001, Bioorganic & medicinal chemistry.

[59]  N. A. Hassan.  Syntheses of Furo[3,2-e][1,2,4]triazolo[1,5-c]pyrimidines and Furo[2`,3`: 5,6]-pyrimido[3,4-b][2,3-e]indolo[1,2,4]triazine as a New Ring System , 2000 .

[60]  Clifton E. Barry,et al.  A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis , 2000, Nature.

[61]  P. D. Cook,et al.  Structure-activity relationships of novel 2-substituted quinazoline antibacterial agents. , 1999, Journal of medicinal chemistry.

[62]  I. Krȩżel.  New derivatives of imidazole as potential anticancer agents. , 1998, Farmaco.

[63]  Angeles Martínez-Grau,et al.  Friedländer reaction on 2-amino-3-cyano-4H-pyrans : Synthesis of derivatives of 4H-pyran [2,3-b] quinoline, new tacrine analogues , 1997 .

[64]  J. Kuthan,et al.  New Developments in the Chemistry of Pyrans , 1995 .

[65]  H. Fujita.  [Anticancer drugs]. , 1995, Nihon rinsho. Japanese journal of clinical medicine.

[66]  Y. Takahata,et al.  Quantitative Structure-Activity Relationships for 1,4-Dihydropyridine Calcium Channel Antagonists (Nifedipine Analogues): A Quantum ChemicalKlassical Approach , 1994 .

[67]  C. Dell,et al.  Preparation of Some New Benzylidenemalononitriles by an SNAr Reaction: Application to Naphtho[1,2-b]pyran Synthesis , 1994 .

[68]  A. Calignano,et al.  Synthesis and pharmacological activity of 2-oxo-(2H) 1-benzopyran-3-carboxamide derivatives , 1993 .

[69]  M. H. Elnagdi,et al.  Nitriles in heterocyclic synthesis: novel synsthesis of benzo[c]-coumarin and of benzo[c]pyrano[3,2-c]quinoline derivatives , 1987 .

[70]  F. Denizot,et al.  Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. , 1986, Journal of immunological methods.

[71]  S. Sherif,et al.  Activated nitriles in heterocyclic synthesis: A novel synthesis of 4-azoloyl-2-aminoquinolines. , 1982 .

[72]  A. Zubenko,et al.  Research on unsaturated azole derivatives , 1978 .

[73]  J. Lombardino,et al.  Preparation and antiinflammatory activity of some nonacidic trisubstituted imidazoles. , 1974, Journal of medicinal chemistry.